|
|
|
|
| LEADER |
02093nmm a2200313 u 4500 |
| 001 |
EB000421042 |
| 003 |
EBX01000000000000000274124 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
131104 ||| eng |
| 020 |
|
|
|a 9783319010502
|
| 100 |
1 |
|
|a Wakabayashi, Ichiro
|e [editor]
|
| 245 |
0 |
0 |
|a Interdisciplinary Concepts in Cardiovascular Health
|h Elektronische Ressource
|b Volume II: Secondary Risk Factors
|c edited by Ichiro Wakabayashi, Klaus Groschner
|
| 250 |
|
|
|a 1st ed. 2013
|
| 260 |
|
|
|a Cham
|b Springer International Publishing
|c 2013, 2013
|
| 300 |
|
|
|a XIII, 137 p. 22 illus., 18 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Hypertension and vascular dysfunction -- Obesity and diabetes -- Hyper- and dyslipoproteinemias -- Hyperuricemia -- Proteomics towards biomarkers discovery and risk assessment
|
| 653 |
|
|
|a Metabolic diseases
|
| 653 |
|
|
|a Molecular Medicine
|
| 653 |
|
|
|a Molecular biology
|
| 653 |
|
|
|a Health Promotion and Disease Prevention
|
| 653 |
|
|
|a Health promotion
|
| 653 |
|
|
|a Metabolic Diseases
|
| 700 |
1 |
|
|a Groschner, Klaus
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-3-319-01050-2?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 611.01816
|
| 520 |
|
|
|a This book provides an introduction to the principles of both cardiovascular epidemiology and molecular pathophysiology; as a unique aspect, it also outlines and discusses the molecular concepts underlying epidemiological observations. This second volume is focused on all aspects concerning “secondary risk factors” in terms of diseases associated with enhanced risk for cardiovascular events. The book promotes the use of interdisciplinary approaches in the field of preventive medicine based on recent advances in molecular and cellular pathophysiology. The book offers a valuable resource for researchers in basic biomedical fields and clinical scientists alike, as well as guidelines for novel avenues of research in both basic pathophysiology and cardiovascular therapy and prevention
|